Literature DB >> 12545192

Transport functions and physiological significance of 76 kDa Ral-binding GTPase activating protein (RLIP76).

Sanjay Awasthi1, Rajendra Sharma, Yusong Yang, Sharad S Singhal, Slawomir Pikula, Joanna Bandorowicz-Pikula, Shivendra V Singh, Piotr Zimniak, Yogesh C Awasthi.   

Abstract

We have recently demonstrated that a previously known Ral-binding GTPase activating protein, RLIP76, can also catalyze ATP-dependent transport of various structurally unrelated xeno- and endobiotics irrespective of their net charge (Awasthi et al., 2000, Biochemistry, 39: 9327). RLIP76 is a non-ATP binding cassette (ABC) protein but it has two ATP-binding sites and shows basal ATPase activity which is stimulated in the presence of its transport substrates (allocrites) such as doxorubicin (DOX) and S-(2,4-dinitrophenyl) glutathione (DNP-SG). Proteoliposomes reconstituted with purified RLIP76 catalyze ATP-dependent, saturable transport of DOX, as well as of glutathione-conjugates including leukotrienes (LTC4) and the GSH-conjugate of 4-hydroxynonenal (GS-HNE). In erythrocytes the majority of transport activity for DOX, GS-HNE, and LTC4 is accounted for by RLIP76. Cells exposed to mild oxidative stress show a rapid and transient induction of RLIP76 resulting in an increased efflux of GS-HNE and acquire resistance to oxidative stress mediated toxicity and apoptosis. Cells transfected with RLIP76 acquire resistance to DOX through increased efflux of the drug suggesting its possible role in the mechanisms of drug-resistance. In this article, we discuss the significance of transport functions of RLIP76 highlighting its role in the defense mechanisms against oxidative injury, and modulation of signaling mechanisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12545192     DOI: 024904855

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  12 in total

1.  Pharmacogenetics of ABCB5, ABCC5 and RLIP76 and doxorubicin pharmacokinetics in Asian breast cancer patients.

Authors:  S Lal; N Sutiman; L L Ooi; Z W Wong; N S Wong; P C S Ang; B Chowbay
Journal:  Pharmacogenomics J       Date:  2016-03-15       Impact factor: 3.550

Review 2.  Regulatory roles of glutathione-S-transferases and 4-hydroxynonenal in stress-mediated signaling and toxicity.

Authors:  Yogesh C Awasthi; Kota V Ramana; Pankaj Chaudhary; Satish K Srivastava; Sanjay Awasthi
Journal:  Free Radic Biol Med       Date:  2016-10-26       Impact factor: 7.376

3.  RLIP76 regulates HIF-1 activity, VEGF expression and secretion in tumor cells, and secretome transactivation of endothelial cells.

Authors:  Seunghyung Lee; Lawrence E Goldfinger
Journal:  FASEB J       Date:  2014-06-13       Impact factor: 5.191

4.  Ras-related small GTPases RalA and RalB regulate cellular survival after ionizing radiation.

Authors:  Ambrose R Kidd; Jared L Snider; Timothy D Martin; Sarah F Graboski; Channing J Der; Adrienne D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-07       Impact factor: 7.038

5.  Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis.

Authors:  Paola Margutti; Paola Matarrese; Fabrizio Conti; Tania Colasanti; Federica Delunardo; Antonella Capozzi; Tina Garofalo; Elisabetta Profumo; Rachele Riganò; Alessandra Siracusano; Cristiano Alessandri; Bruno Salvati; Guido Valesini; Walter Malorni; Maurizio Sorice; Elena Ortona
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

6.  RALBP1/RLIP76 depletion in mice suppresses tumor growth by inhibiting tumor neovascularization.

Authors:  Seunghyung Lee; Jeremy G T Wurtzel; Sharad S Singhal; Sanjay Awasthi; Lawrence E Goldfinger
Journal:  Cancer Res       Date:  2012-08-17       Impact factor: 12.701

7.  Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation.

Authors:  Pataje G S Prasanna; Deepa Narayanan; Kory Hallett; Eric J Bernhard; Mansoor M Ahmed; Gregory Evans; Bhadrasain Vikram; Michael Weingarten; C Norman Coleman
Journal:  Radiat Res       Date:  2015-08-18       Impact factor: 2.841

8.  The RalB-RLIP76 complex reveals a novel mode of ral-effector interaction.

Authors:  R Brynmor Fenwick; Louise J Campbell; Karthik Rajasekar; Sunil Prasannan; Daniel Nietlispach; Jacques Camonis; Darerca Owen; Helen R Mott
Journal:  Structure       Date:  2010-08-11       Impact factor: 5.006

9.  RLIP76, a non-ABC transporter, and drug resistance in epilepsy.

Authors:  Sanjay Awasthi; Kerri L Hallene; Vince Fazio; Sharad S Singhal; Luca Cucullo; Yogesh C Awasthi; Gabriele Dini; Damir Janigro
Journal:  BMC Neurosci       Date:  2005-09-27       Impact factor: 3.288

10.  Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis.

Authors:  Sharda P Singh; Jihyun Lee; Chhanda Bose; Hongzhi Li; Yate-Ching Yuan; Ashly Hindle; Sharad S Singhal; Jonathan Kopel; Philip T Palade; Catherine Jones; Rakhshanda L Rahman; Sanjay Awasthi
Journal:  Cancers (Basel)       Date:  2021-07-02       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.